Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
ADGRG5	"GPR114, PGR27"	ENSG00000159618	"Adhesion G protein-coupled receptor G5"	Q8IZF4	16	57542643-57591681	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 3.9;lymphoid tissue: 10.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 6.2;dendritic cells: 30.5;Microglial cells: 10.9;NK-cells: 27.5;Plasma cells: 16.9;T-cells: 6.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 125.9"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"Leukemia: 9.6;lymphoma: 6.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007133	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Nuclear membrane, Vesicles"	Nucleoplasm	"HPA007133: AB_1849253"	"unprognostic (6.11e-3)"	"prognostic favorable (4.25e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.09e-4)"	"unprognostic (3.80e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.91e-1)"	"unprognostic (4.37e-3)"	"unprognostic (7.69e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.32e-3)"
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 68.3;intestine: 53.2;lung: 39.5;lymphoid tissue: 106.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 74.4;Kupffer cells: 76.7;monocytes: 87.2;NK-cells: 81.1;Syncytiotrophoblasts: 74.6;T-cells: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 92.8;lymphoma: 78.9;Myeloma: 97.0"	"Colon - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA019816, HPA079252"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA019816: AB_1853923, HPA079252: "	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472264-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 119.7;lymphoid tissue: 100.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 80.3;Early spermatids: 119.5;Hofbauer cells: 50.7;NK-cells: 176.8;Spermatocytes: 78.1;T-cells: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 388.9"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Leukemia: 35.3;lymphoma: 19.9;Myeloma: 14.7"	"Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 72.3;Plasma cells: 33.1;T-cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Non-specific - Antiviral immune response"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"
C11orf21		ENSG00000110665	"Chromosome 11 open reading frame 21"	Q9P2W6	11	2295628-2303049	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 50.4;heart muscle: 20.0;lymphoid tissue: 14.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 69.1;Kupffer cells: 21.8;Langerhans cells: 19.5;monocytes: 54.7;NK-cells: 37.9;T-cells: 15.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	9	"Leukemia: 24.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Cardiomyocytes, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"									HPA037607	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"HPA037607: AB_10672909"	"unprognostic (5.25e-3)"	"unprognostic (2.65e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.61e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.58e-4)"	"unprognostic (8.98e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.84e-4)"	"unprognostic (8.50e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.07e-2)"
CAMK4	"CaMK-GR, CaMKIV"	ENSG00000152495	"Calcium/calmodulin dependent protein kinase IV"	Q16566	5	111223653-111494886	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Inflammatory response"	"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 70.4;lymphoid tissue: 55.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 361.0;Excitatory neurons: 209.0;Inhibitory neurons: 128.6;Late spermatids: 118.4;Oligodendrocyte precursor cells: 127.6;T-cells: 88.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"basal ganglia: 30.6;cerebellum: 70.4"	"Group enriched"	"Detected in many"	4	"MAIT T-cell: 24.3;memory CD4 T-cell: 17.3;memory CD8 T-cell: 13.5;naive CD4 T-cell: 33.1;naive CD8 T-cell: 18.5;T-reg: 21.3"	"Lineage enriched"	"Detected in many"	23	"T-cells: 33.1"	"Cancer enhanced"	"Detected in many"		"Neuroblastoma: 27.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - Hepatic stellate cells, Skin - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004347, HPA011753, HPA017206"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Nucleoli fibrillar center"		"CAB004347: AB_626793, HPA011753: AB_1845950, HPA017206: AB_1845949"	"unprognostic (2.99e-5)"	"unprognostic (7.19e-2)"	"unprognostic (3.43e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.66e-4)"	"unprognostic (7.22e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.23e-5)"	"unprognostic (2.42e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"
CCDC88B	"BRLZ, CCDC88, FLJ00354, FLJ37970, GIPIE, HkRP3"	ENSG00000168071	"Coiled-coil domain containing 88B"	A6NC98	11	64340204-64357534	"Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.6;lymphoid tissue: 86.1"	"Cell type enhanced"	"Detected in many"		"NK-cells: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"head and neck cancer: 6.1;Leukemia: 21.8;lymphoma: 23.4;Myeloma: 15.7"	"Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA026652	Approved		Supported	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: RS4;11 - Unknown function"	"Cluster 40: Plasma cells - Humoral immune response"	"Centrosome, Cytosol"	Nucleoplasm	"HPA026652: AB_1846168"	"unprognostic (1.18e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.36e-1)"	"prognostic favorable (1.48e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (7.65e-5)"	"unprognostic (3.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.83e-2)"
CCR5	"CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22"	ENSG00000160791	"C-C motif chemokine receptor 5"	P51681	3	46370854-46376206	"CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.0"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 10.3;Langerhans cells: 41.3;Macrophages: 11.6;T-cells: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 39.7"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 1.5;Myeloma: 1.4"	"Lung - T-cells, Prostate - T-cells, Skin - T-cells, Stomach - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"				"unprognostic (4.32e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.89e-3)"	"prognostic favorable (7.42e-5)"	"unprognostic (1.80e-2)"	"prognostic favorable (9.33e-5)"	"unprognostic (3.38e-3)"	"unprognostic (9.90e-3)"	"unprognostic (7.65e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.14e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.42e-2)"
CD226	"DNAM-1, DNAM1, PTA1, TLiSA1"	ENSG00000150637	"CD226 molecule"	Q15762	18	69831158-69961803	"CD markers, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 20.2;parathyroid gland: 62.4"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 21.9;NK-cells: 103.3;Oligodendrocytes: 25.1;Schwann cells: 30.0;T-cells: 52.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 36.6;MAIT T-cell: 13.4;memory CD4 T-cell: 28.8;memory CD8 T-cell: 22.5;naive CD4 T-cell: 15.8;naive CD8 T-cell: 17.3;NK-cell: 29.7;T-reg: 11.3"	"Group enriched"	"Detected in many"	11	"NK-cells: 29.7;T-cells: 36.6"	"Group enriched"	"Detected in some"	6	"Leukemia: 7.1;lymphoma: 10.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Prostate - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA015715, HPA015865"	Supported		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		NA	No		20000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"HPA015715: AB_1846278, HPA015865: "	"unprognostic (1.42e-4)"	"unprognostic (1.30e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.49e-5)"	"unprognostic (4.15e-1)"	"unprognostic (9.52e-4)"	"unprognostic (3.68e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.31e-3)"	"unprognostic (8.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.58e-2)"
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862887	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 10.0;lymphoid tissue: 16.8"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 12.7;Macrophages: 7.4;monocytes: 15.7;NK-cells: 40.4;T-cells: 18.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	4	"basophil: 472.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 472.1"	"Cancer enriched"	"Detected in some"	14	"Leukemia: 15.0"	"Adipose subcutaneous - T-cells, Adipose visceral - Mesothelial cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		280000	"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"
CD28		ENSG00000178562	"CD28 molecule"	P10747	2	203706475-203738912	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 30.8;placenta: 14.8"	"Group enriched"	"Detected in some"	10	"Hofbauer cells: 31.4;T-cells: 58.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 101.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 101.9"	"Cancer enriched"	"Detected in some"	14	"Myeloma: 98.7"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Skin - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.0"	"Not detected"	"Not detected"			HPA070003	Enhanced					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 51: Myeloma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"HPA070003: AB_2686226"	"unprognostic (5.54e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (6.07e-5)"	"unprognostic (9.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.78e-5)"	"unprognostic (4.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (7.79e-2)"	"unprognostic (8.96e-2)"
CD37	TSPAN26	ENSG00000104894	"CD37 molecule"	P11049	19	49335171-49343335	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 155.2;intestine: 116.3;lymphoid tissue: 235.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 1698.7;dendritic cells: 539.1;granulocytes: 459.9;Hofbauer cells: 485.4;Langerhans cells: 414.6;monocytes: 749.0;NK-cells: 383.4;T-cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 70.9;lymphoma: 194.7"	"Breast - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002492, HPA032120, HPA032121"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	"Golgi apparatus"	"Plasma membrane"	"CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163"	"unprognostic (4.30e-3)"	"unprognostic (2.39e-3)"	"unprognostic (8.85e-2)"	"prognostic favorable (4.51e-4)"	"unprognostic (5.46e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.76e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (7.71e-2)"
CD52	"CDW52, EDDM5, HE5"	ENSG00000169442	"CD52 molecule"	P31358	1	26317958-26320523	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins"			"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"epididymis: 36173.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 1905.6;Hofbauer cells: 979.8;Langerhans cells: 748.0;Macrophages: 564.3;monocytes: 1697.8;NK-cells: 487.7;T-cells: 1243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 272.6;lymphoma: 602.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - Macrophages, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 19: Macrophages - Innate immune response"				"prognostic favorable (1.85e-5)"	"unprognostic (3.28e-3)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.06e-4)"	"unprognostic (4.18e-2)"	"prognostic favorable (4.45e-4)"	"unprognostic (9.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.73e-3)"	"unprognostic (6.27e-2)"	"unprognostic (4.58e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (3.64e-1)"	"unprognostic (6.14e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.26e-1)"
CD69	CLEC2C	ENSG00000110848	"CD69 molecule"	Q07108	12	9752486-9760901	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 169.1;lymphoid tissue: 94.4"	"Group enriched"	"Detected in many"	5	"B-cells: 947.5;granulocytes: 1937.7;NK-cells: 517.3;T-cells: 1179.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"NK-cells: 26.7;T-cells: 30.8"	"Group enriched"	"Detected in some"	6	"Leukemia: 44.2;lymphoma: 26.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002503, HPA050525"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"CAB002503: AB_563625, HPA050525: AB_2681157"	"prognostic favorable (3.31e-5)"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.10e-3)"	"unprognostic (4.76e-3)"	"unprognostic (9.53e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (7.87e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.32e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.65e-1)"
CLEC2D	"CLAX, LLT1, OCIL"	ENSG00000069493	"C-type lectin domain family 2 member D"	Q9UHP7	12	9664969-9699553	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 94.6;Early spermatids: 79.1;NK-cells: 136.3;T-cells: 200.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"gdT-cell: 188.1;MAIT T-cell: 114.5;memory B-cell: 95.0;memory CD4 T-cell: 183.3;memory CD8 T-cell: 208.7;naive B-cell: 127.5;naive CD4 T-cell: 192.3;naive CD8 T-cell: 223.0;T-reg: 175.2"	"Group enriched"	"Detected in all"	11	"B-cells: 127.5;T-cells: 223.0"	"Group enriched"	"Detected in all"	4	"Leukemia: 18.0;lymphoma: 53.3;Myeloma: 16.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - T-cells, Thyroid - T-cells"									"HPA017649, HPA047584"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Golgi apparatus"		"HPA017649: AB_1846912, HPA047584: "	"unprognostic (1.09e-3)"	"prognostic favorable (1.37e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.77e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.85e-11)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.44e-1)"	"prognostic favorable (1.68e-7)"
CRTAM	CD355	ENSG00000109943	"Cytotoxic and regulatory T cell molecule"	O95727	11	122838500-122872643	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Cell adhesion, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 38.2"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 14.2;Macrophages: 10.9;monocytes: 13.5;NK-cells: 55.4;T-cells: 50.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	9	"cerebellum: 38.2"	"Immune cell enhanced"	"Detected in many"		"NK-cell: 54.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 54.0;T-cells: 33.3"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Liver - T-cells, Prostate - T-cells"	"Region enriched"	"Detected in some"	44	"cerebellum: 102.6"	"Region enriched"	"Detected in all"	7	"cerebellum: 25.7"							NA	NA		6800000	"Cluster 48: NK-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"				"unprognostic (3.51e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.25e-4)"	"unprognostic (1.25e-1)"	"unprognostic (3.66e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-4)"	"unprognostic (6.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.59e-2)"
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949269-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 1095.6"	"Cell type enhanced"	"Detected in many"		"granulocytes: 242.8;Langerhans cells: 686.4;NK-cells: 1685.7;T-cells: 489.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"gdT-cell: 1287.0"	"Group enriched"	"Detected in all"	27	"granulocytes: 342.2;NK-cells: 655.3;T-cells: 1287.0"	"Group enriched"	"Detected in many"	6	"Leukemia: 132.5;lymphoma: 48.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Skeletal muscle - Neutrophils, Thyroid - T-cells"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"	NA	NA		26000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA040442: AB_2676988"	"prognostic favorable (6.55e-4)"	"prognostic favorable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favorable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favorable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"
CTLA4	"CD, CD152, CELIAC3, CTLA-4, GSE, IDDM12"	ENSG00000163599	"Cytotoxic T-lymphocyte associated protein 4"	P16410	2	203867771-203873965	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"Diabetes mellitus, Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 37.4"	"Group enriched"	"Detected in some"	8	"Schwann cells: 28.4;T-cells: 54.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	7	"T-reg: 44.5"	"Lineage enriched"	"Detected in single"	445	"T-cells: 44.5"	"Cancer enhanced"	"Detected in some"		"Gastric cancer: 2.9;skin cancer: 5.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Kidney - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: DU4475 - Unknown function"	"Cluster 1: T-cells - Immune response"				"unprognostic (1.92e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.47e-3)"	"unprognostic (9.89e-6)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.76e-1)"	"unprognostic (9.86e-10)"	"unprognostic (4.13e-2)"	"unprognostic (7.45e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-2)"
CXCR6	"BONZO, CD186, STRL33, TYMSTR"	ENSG00000172215	"C-X-C motif chemokine receptor 6"	O00574	3	45940933-45948351	"CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 88.1;T-cells: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 445.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 445.8"	"Cancer enhanced"	"Detected in some"		"Gallbladder cancer: 2.0"	"Kidney - T-cells, Lung - T-cells, Pancreas - T-cells, Prostate - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 1: T-cells - Immune response"				"unprognostic (2.05e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.77e-3)"	"prognostic favorable (6.74e-6)"	"unprognostic (6.67e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.65e-4)"	"unprognostic (8.57e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.57e-2)"
CYTIP	"B3-1, CASP, CYBR, CYTHIP, HE, PSCDBP"	ENSG00000115165	"Cytohesin 1 interacting protein"	O60759	2	157414619-157488961	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 105.6;lymphoid tissue: 114.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.4;Langerhans cells: 667.1;monocytes: 789.8;NK-cells: 358.3;Plasma cells: 335.3;T-cells: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"lymphoma: 81.8;Myeloma: 106.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA007191	Approved		Supported	Nucleoplasm,Cytosol		No	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 11: Lymphoma - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Cytosol	Nucleoplasm	"HPA007191: AB_1855801"	"unprognostic (3.61e-3)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"prognostic favorable (9.12e-4)"	"unprognostic (5.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.78e-2)"
DENND1C	"FAM31C, FLJ22757"	ENSG00000205744	"DENN domain containing 1C"	Q8IV53	19	6467207-6482557	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.2;intestine: 14.4;lymphoid tissue: 35.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.4;dendritic cells: 15.9;Hofbauer cells: 17.1;monocytes: 22.3;NK-cells: 33.8;T-cells: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	30	"Leukemia: 20.9;lymphoma: 27.0;Myeloma: 8.4"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042758, HPA042839"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Cytosol	"Nucleoplasm, Centrosome"	"HPA042758: AB_10962357, HPA042839: AB_10959898"	"unprognostic (5.94e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (1.23e-4)"	"unprognostic (7.76e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (8.95e-4)"	"prognostic favorable (7.51e-14)"	"unprognostic (1.37e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.53e-2)"	"prognostic favorable (5.62e-4)"
DTHD1	FLJ16686	ENSG00000197057	"Death domain containing 1"	Q6ZMT9	4	36281616-36347511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 11.8;fallopian tube: 13.7;lung: 3.5;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 110.7;Endometrial ciliated cells: 135.2;NK-cells: 67.2;Respiratory ciliated cells: 174.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 56: Ciliated cells - Cilium assembly"				"unprognostic (9.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.45e-5)"	"unprognostic (5.12e-3)"	"unprognostic (9.11e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.05e-5)"	"unprognostic (1.19e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.12e-3)"
DUSP2	PAC-1	ENSG00000158050	"Dual specificity phosphatase 2"	Q05923	2	96143169-96145440	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 129.5"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 355.4;Langerhans cells: 1081.0;monocytes: 470.1;NK-cells: 831.5;T-cells: 786.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebral cortex: 55.0"	"Immune cell enhanced"	"Detected in all"		"gdT-cell: 199.3"	"Group enriched"	"Detected in all"	10	"NK-cells: 148.1;T-cells: 199.3"	"Cancer enriched"	"Detected in many"	4	"lymphoma: 70.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA071920			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 1: T-cells - Immune response"	"Nuclear membrane"	Nucleoplasm	"HPA071920: AB_2686472"	"unprognostic (2.69e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.15e-1)"	"unprognostic (5.46e-3)"	"unprognostic (3.32e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (4.97e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-3)"
FCHO1	KIAA0290	ENSG00000130475	"FCH and mu domain containing endocytic adaptor 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 59.5;lymphoid tissue: 24.3;skin 1: 22.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 19.5;Langerhans cells: 17.7;Oligodendrocytes: 44.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 33.4;lymphoma: 45.9"	"Adipose subcutaneous - Macrophages, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Skin - Keratinocyte (granular), Testis - Spermatogonia, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 4: Platelets - Platelet activation"	Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"
FCRL3	"CD307c, FCRH3, IFGP3, IRTA3, SPAP2, SPAP2a, SPAP2b, SPAP2c, SPAP2d, SPAP2e"	ENSG00000160856	"Fc receptor like 3"	Q96P31	1	157674321-157700769	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 49.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 46.2;Late spermatids: 10.8;NK-cells: 29.1;T-cells: 9.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 35.3"	"Group enriched"	"Detected in many"	54	"B-cells: 35.3;NK-cells: 20.4;T-cells: 19.0"	"Cancer enriched"	"Detected in single"	67	"lymphoma: 14.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Testis - Late spermatids"					"Low region specificity"	"Detected in some"			HPA048022	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA048022: AB_2732541"	"unprognostic (6.73e-3)"	"unprognostic (5.06e-4)"	"unprognostic (1.13e-2)"	"unprognostic (2.08e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.74e-5)"	"unprognostic (1.09e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.46e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.69e-2)"
FCRL6	"FcRH6, FLJ16056, IFGP6"	ENSG00000181036	"Fc receptor like 6"	Q6DN72	1	159800511-159816257	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 7.9;lymphoid tissue: 12.8"	"Cell type enriched"	"Detected in some"	4	"NK-cells: 107.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 142.9;memory CD8 T-cell: 134.3;naive CD8 T-cell: 102.8;NK-cell: 51.3"	"Group enriched"	"Detected in many"	26	"NK-cells: 51.3;T-cells: 142.9"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.64e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-5)"	"unprognostic (3.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.18e-2)"
GPR18		ENSG00000125245	"G protein-coupled receptor 18"	Q14330	13	99254732-99261744	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 9.7;lymphoid tissue: 38.9;testis: 13.0"	"Group enriched"	"Detected in some"	4	"Early spermatids: 88.7;Late spermatids: 242.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 65.3;NK-cells: 52.9;T-cells: 41.9"	"Group enriched"	"Detected in some"	13	"Leukemia: 6.8;lymphoma: 21.4"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013873	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 36: Spermatids - Spermatogenesis"			"HPA013873: AB_1849285"	"unprognostic (3.87e-6)"	"unprognostic (1.31e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.31e-6)"	"unprognostic (2.89e-1)"	"unprognostic (7.55e-4)"	"unprognostic (4.27e-5)"	"unprognostic (3.45e-3)"	"unprognostic (2.31e-3)"	"unprognostic (5.43e-2)"	"unprognostic (9.70e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.20e-6)"	"unprognostic (9.96e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.92e-3)"
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2 related adaptor protein 2"	O75791	22	39901084-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"lymphoid tissue: 184.8"	"Group enriched"	"Detected in many"	7	"Erythroid cells: 28.7;granulocytes: 107.3;NK-cells: 43.6;T-cells: 56.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 51.4;MAIT T-cell: 38.2;memory CD4 T-cell: 37.5;memory CD8 T-cell: 56.2;naive CD4 T-cell: 31.3;naive CD8 T-cell: 58.2;T-reg: 35.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 58.2"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 27.7"	"Adipose visceral - T-cells, Kidney - T-cells, Pancreas - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 4: Platelets - Platelet activation"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 68.2;lymphoid tissue: 37.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2884.6;NK-cells: 1948.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 6765.2"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 6765.2"	"Cancer enriched"	"Detected in some"	51	"lymphoma: 378.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Skin - T-cells, Thyroid - T-cells"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"	NA	NA	2170		"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favorable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"
HEATR9	"C17orf66, FLJ32830"	ENSG00000270379	"HEAT repeat containing 9"	A2RTY3	17	35854946-35868891	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	20	"testis: 10.1"	"Group enriched"	"Detected in some"	23	"Early spermatids: 79.3;Late spermatids: 48.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA023129	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 36: Spermatids - Spermatogenesis"			"HPA023129: AB_1845599"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.44e-4)"	"unprognostic (1.30e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.61e-10)"	"unprognostic (6.78e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (5.61e-3)"
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 245.4;dendritic cells: 311.4;Hofbauer cells: 317.2;Langerhans cells: 582.6;Macrophages: 259.7;monocytes: 224.8;Proximal enterocytes: 283.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cancer enhanced"	"Detected in many"		"lymphoma: 18.7;prostate cancer: 12.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Lung - Macrophages, Thyroid - T-cells"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004182-33009591	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 63.7;dendritic cells: 54.8;Langerhans cells: 77.9;Macrophages: 40.5;monocytes: 27.4;Schwann cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 17.8;naive B-cell: 21.0"	"Group enriched"	"Detected in many"	11	"B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 15.1"	"Adipose visceral - T-cells, Heart muscle - T-cells, Prostate - T-cells, Testis - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045038, HPA076922"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 75: Myeloid cells - Innate immune response"			"HPA045038: AB_10959457, HPA076922: "	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"
HSH2D	"ALX, FLJ14886, HSH2"	ENSG00000196684	"Hematopoietic SH2 domain containing"	Q96JZ2	19	16134028-16158575	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 47.0;lymphoid tissue: 37.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 66.5;Gastric mucus-secreting cells: 39.9;NK-cells: 140.1;Plasma cells: 110.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 232.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Leukemia: 50.3;lymphoma: 32.9;Myeloma: 30.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036616			Approved	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 40: Plasma cells - Humoral immune response"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA036616: AB_10671962"	"unprognostic (1.69e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (9.46e-6)"	"unprognostic (1.06e-1)"	"unprognostic (5.50e-3)"	"unprognostic (5.21e-3)"	"unprognostic (9.35e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (6.49e-6)"	"unprognostic (9.17e-3)"	"unprognostic (6.18e-2)"	"unprognostic (3.21e-2)"	"prognostic favorable (3.47e-5)"
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159740	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 11.5;lymphoid tissue: 7.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 82.4;T-cells: 208.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.5;memory CD4 T-cell: 2.4;memory CD8 T-cell: 6.6;naive CD8 T-cell: 3.7"	"Lineage enriched"	"Detected in single"	7	"T-cells: 6.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB010344	Approved				"Secreted to blood"	NA	NA	1470		"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"
IKZF1	"hIk-1, Hs.54452, IKAROS, LyF-1, PPP1R92, ZNFN1A1"	ENSG00000185811	"IKAROS family zinc finger 1"	Q13422	7	50304068-50405101	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 173.0;lymphoid tissue: 112.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 161.5;dendritic cells: 378.3;Langerhans cells: 115.3;monocytes: 150.7;NK-cells: 323.4;T-cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	131	"Leukemia: 92.0;lymphoma: 124.9;Myeloma: 43.3"	"Adipose visceral - T-cells, Colon - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009247, HPA035221, HPA035222"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm	Cytosol	"CAB009247: AB_2124699, HPA035221: AB_2674524, HPA035222: AB_2674525"	"prognostic favorable (4.28e-4)"	"prognostic favorable (2.02e-4)"	"unprognostic (2.49e-3)"	"unprognostic (2.41e-3)"	"unprognostic (5.59e-1)"	"prognostic favorable (8.63e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.67e-2)"
IKZF3	"Aiolos, ZNFN1A3"	ENSG00000161405	"IKAROS family zinc finger 3"	Q9UKT9	17	39757718-39864312	"Predicted intracellular proteins, Transcription factors"	"B-cell activation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 12.1;lymphoid tissue: 41.0"	"Group enriched"	"Detected in many"	6	"B-cells: 132.3;granulocytes: 38.5;NK-cells: 136.0;Plasma cells: 78.4;Serous glandular cells: 48.9;T-cells: 127.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.2;T-cells: 28.8"	"Group enriched"	"Detected in many"	8	"lymphoma: 46.8;Myeloma: 34.0"	"Adipose subcutaneous - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA024377, HPA073266"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"	Nucleoplasm	Cytosol	"HPA024377: AB_1859477, HPA073266: "	"unprognostic (5.43e-3)"	"prognostic favorable (6.85e-6)"	"unprognostic (6.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.93e-2)"	"prognostic favorable (4.16e-4)"	"unprognostic (1.36e-2)"	"unprognostic (3.14e-3)"	"prognostic favorable (5.42e-4)"	"unprognostic (8.03e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (9.13e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.05e-3)"
IL12RB1	"CD212, IL12RB"	ENSG00000096996	"Interleukin 12 receptor subunit beta 1"	P42701	19	18058995-18098944	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 24.6"	"Cell type enhanced"	"Detected in some"		"Kupffer cells: 10.7;monocytes: 34.1;NK-cells: 55.5;Plasma cells: 12.1;T-cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Leukemia: 9.3;lymphoma: 22.4;Myeloma: 27.4"	"Breast - T-cells, Lung - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA074414			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"HPA074414: AB_2686687"	"unprognostic (7.70e-3)"	"prognostic favorable (3.41e-4)"	"unprognostic (9.08e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.93e-2)"
IL21R	CD360	ENSG00000103522	"Interleukin 21 receptor"	Q9HBE5	16	27402174-27452042	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;lymphoid tissue: 24.7"	"Cell type enhanced"	"Detected in some"		"B-cells: 12.3;Hofbauer cells: 7.7;Langerhans cells: 19.5;monocytes: 11.5;NK-cells: 29.6;T-cells: 24.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"lymphoma: 46.5;Myeloma: 25.9"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA042296	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane, Cytosol"		"HPA042296: AB_10806236"	"unprognostic (2.91e-2)"	"unprognostic (2.65e-3)"	"unprognostic (6.64e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.14e-1)"	"prognostic favorable (7.29e-4)"	"unprognostic (8.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.50e-6)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-10)"	"unprognostic (8.79e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.58e-2)"
IL7R	"CD127, IL7RA"	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 183.7"	"Cell type enhanced"	"Detected in many"		"NK-cells: 204.9;Serous glandular cells: 318.6;T-cells: 1261.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 102.1;MAIT T-cell: 369.5;memory CD4 T-cell: 213.8;memory CD8 T-cell: 151.1;naive CD4 T-cell: 179.5;naive CD8 T-cell: 124.6;NK-cell: 113.2"	"Group enriched"	"Detected in all"	33	"NK-cells: 113.2;T-cells: 369.5"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Colon - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010215, HPA067550"			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		610000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Plasma membrane"		"CAB010215: AB_673727, HPA067550: "	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 12.9;Inhibitory neurons: 58.7;Plasma cells: 54.8;T-cells: 23.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 4.9;T-cells: 14.3"	"Cancer enhanced"	"Detected in some"		"lymphoma: 7.2;Myeloma: 25.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Skin - T-cells, Testis - Spermatocytes, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 2: T-cells - T-cell receptor"			"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023714	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.1;brain: 21.6;retina: 21.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 21.8;Bipolar cells: 26.6;Cone photoreceptor cells: 34.5;Late spermatids: 84.4;monocytes: 22.6;NK-cells: 21.9;Rod photoreceptor cells: 28.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Group enriched"	"Detected in many"	8	"Leukemia: 30.4;lymphoma: 35.2;Myeloma: 74.8"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"		Yes	No			"Cluster 11: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 51: Late spermatids - Spermatogenesis"	"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"
KLRC1	"CD159a, NKG2, NKG2-A, NKG2-B"	ENSG00000134545	"Killer cell lectin like receptor C1"	P26715	12	10442264-10454685	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.7"	"Group enriched"	"Detected in some"	5	"NK-cells: 229.4;T-cells: 105.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 229.2;NK-cell: 367.6"	"Group enriched"	"Detected in many"	46	"NK-cells: 367.6;T-cells: 229.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - NK-cells (Liver), Pancreas - T-cells, Prostate - T-cells"									HPA058052			Approved	"Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane"		"HPA058052: AB_2683589"	"unprognostic (8.17e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.58e-7)"	"unprognostic (3.57e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.73e-4)"	"unprognostic (4.13e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.18e-4)"	"unprognostic (1.88e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.92e-3)"
KLRC3	NKG2-E	ENSG00000205810	"Killer cell lectin like receptor C3"	Q07444	12	10412315-10420595	"Predicted membrane proteins"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.9;brain: 2.1;lymphoid tissue: 4.0"	"Group enriched"	"Detected in some"	5	"NK-cells: 17.4;Oligodendrocyte precursor cells: 34.7;T-cells: 9.4"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"NK-cell: 63.1"	"Lineage enriched"	"Detected in many"	6	"NK-cells: 63.1"	"Cancer enhanced"	"Detected in some"		"lymphoma: 6.8;thyroid cancer: 5.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"									"HPA039910, HPA062570"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"	Vesicles		"HPA039910: , HPA062570: AB_2684795"	"unprognostic (8.92e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.32e-1)"	"unprognostic (5.07e-3)"		"unprognostic (2.48e-1)"	"unprognostic (3.22e-1)"		"unprognostic (9.12e-2)"		"unprognostic (3.52e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.15e-1)"	
KLRD1	CD94	ENSG00000134539	"Killer cell lectin like receptor D1"	Q13241	12	10226058-10329608	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 17.0"	"Cell type enriched"	"Detected in many"	4	"NK-cells: 1409.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"gdT-cell: 512.6;memory CD8 T-cell: 217.7;naive CD8 T-cell: 218.7;NK-cell: 737.5"	"Group enriched"	"Detected in many"	68	"NK-cells: 737.5;T-cells: 512.6"	"Low cancer specificity"	"Detected in some"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Prostate - T-cells, Stomach - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA069688	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA069688: AB_2686170"	"unprognostic (3.75e-2)"	"unprognostic (2.15e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.94e-3)"	"unprognostic (4.53e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.37e-2)"
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1093.3;dendritic cells: 320.2;Ductal cells: 270.7;Exocrine glandular cells: 811.3;T-cells: 571.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Leukemia: 28.4;lymphoma: 55.6"	"Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Skin - Langerhans cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"
MATK	"CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101"	ENSG00000007264	"Megakaryocyte-associated tyrosine kinase"	P42679	19	3777970-3802129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 20.5;brain: 41.9"	"Cell type enhanced"	"Detected in many"		"granulocytes: 70.6;Hofbauer cells: 50.4;NK-cells: 303.1;T-cells: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 76.8"	"Group enriched"	"Detected in many"	57	"NK-cells: 76.8;T-cells: 46.2"	"Cancer enhanced"	"Detected in many"		"Leukemia: 52.8"	"Adipose visceral - T-cells, Breast - T-cells, Heart muscle - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004847, HPA066547"	Approved		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Microtubules	"Cytokinetic bridge, Mitotic spindle, Centriolar satellite, Cytosol"	"HPA004847: AB_1079316, HPA066547: "	"prognostic favorable (5.27e-4)"	"unprognostic (1.28e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.39e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.19e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-2)"
MYO1G	HA-2	ENSG00000136286	"Myosin IG"	B0I1T2	7	44962662-44979088	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.6;lymphoid tissue: 27.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 58.8;Kupffer cells: 72.8;Langerhans cells: 76.6;Macrophages: 64.6;monocytes: 252.2;NK-cells: 164.4;T-cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Leukemia: 84.6;lymphoma: 99.5"	"Adipose subcutaneous - T-cells, Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021252	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 23: Langerhans cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA021252: AB_1854254"	"unprognostic (2.74e-2)"	"prognostic favorable (8.26e-4)"	"unprognostic (5.20e-3)"	"unprognostic (9.91e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.54e-3)"	"unprognostic (6.47e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (8.71e-8)"	"unprognostic (3.20e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.85e-1)"	"unprognostic (7.92e-2)"
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	12	"B-cells: 46.1;NK-cells: 143.8;T-cells: 50.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"Leukemia: 2.2;lymphoma: 2.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"					"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 68.3;Granulosa cells: 73.0;Horizontal cells: 52.6;NK-cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Lung - T-cells, Testis - Spermatocytes, Thyroid - T-cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 17: Granulosa cells - Transcription regulation"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"
PARP15	"ARTD7, FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577628-122639047	"Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Glycosyltransferase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 23.1;intestine: 42.1;lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 86.0;granulocytes: 13.0;NK-cells: 41.7;T-cells: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Leukemia: 18.2;lymphoma: 18.0"	"Adipose visceral - T-cells, Colon - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"					"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 62: B-cells - B-cell activation"				"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta associated 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 365.9;esophagus: 92.0;intestine: 236.0;lymphoid tissue: 155.1;stomach 1: 117.5"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1487.4;Distal enterocytes: 1382.1;Extravillous trophoblasts: 711.2;monocytes: 425.9;NK-cells: 741.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 2310.7"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - T-cells, Breast - T-cells, Colon - Colon enterocytes, Prostate - T-cells, Stomach - Gastric mucous cells, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 50: Enterocytes - Absorption"	Cytosol		"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"
PLCB2	FLJ38135	ENSG00000137841	"Phospholipase C beta 2"	Q00722	15	40278176-40307935	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.4;lymphoid tissue: 40.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.7;Kupffer cells: 40.2;Macrophages: 42.0;Microglial cells: 38.3;monocytes: 57.5;NK-cells: 23.1;Schwann cells: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	5	"Leukemia: 35.3"	"Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB009443, HPA041298, HPA068595, HPA069308"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		11000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 33: Macrophages - Degranulation"	"Plasma membrane, Cytosol"		"CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: "	"unprognostic (5.52e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.31e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.20e-5)"	"unprognostic (9.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.13e-1)"
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 33.6;skeletal muscle: 124.5;tongue: 112.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.1;NK-cells: 34.2;Oligodendrocyte precursor cells: 23.6;Oligodendrocytes: 71.0;Skeletal myocytes: 34.6;T-cells: 35.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 23.0;MAIT T-cell: 18.0;memory CD4 T-cell: 24.5;memory CD8 T-cell: 24.5;naive CD4 T-cell: 19.1;naive CD8 T-cell: 17.9;NK-cell: 13.3;T-reg: 39.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 13.3;T-cells: 39.7"	"Cancer enriched"	"Detected in many"	5	"Leukemia: 17.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Alveolar cells type 2, Prostate - T-cells, Skeletal muscle - Skeletal myocytes, Skin - T-cells, Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 1: T-cells - Immune response"	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"
PSTPIP1	"CD2BP1, CD2BP1L, CD2BP1S, H-PIP, PAPAS, PSTPIP"	ENSG00000140368	"Proline-serine-threonine phosphatase interacting protein 1"	O43586	15	76993359-77037475	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Endocytosis, Immunity, Inflammatory response, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 56.6;lymphoid tissue: 33.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 54.7;Kupffer cells: 54.0;Langerhans cells: 38.0;Macrophages: 41.3;monocytes: 32.9;NK-cells: 72.7;T-cells: 64.7;Theca cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Leukemia: 13.3;lymphoma: 11.8"	"Adipose subcutaneous - Macrophages, Heart muscle - Macrophages, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Skeletal muscle - Macrophages, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA010116, HPA010600, HPA072744"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA010116: , HPA010600: AB_1855870, HPA072744: "	"unprognostic (4.42e-3)"	"unprognostic (1.31e-3)"	"unprognostic (3.56e-2)"	"prognostic favorable (4.74e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.12e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (7.36e-9)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.42e-2)"
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase non-receptor type 22"	Q9Y2R2	1	113813811-113871753	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity, Lipid metabolism"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease variant, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;lymphoid tissue: 20.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.0;granulocytes: 38.6;NK-cells: 204.4;T-cells: 143.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 15.4;lymphoma: 22.3;Myeloma: 12.6"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enriched"	"Detected in single"	11	"cerebellum: 5.3"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 506.7;Kupffer cells: 464.5;Macrophages: 507.9;monocytes: 1400.2;NK-cells: 1356.4;T-cells: 1034.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Leukemia: 117.5;lymphoma: 158.9"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"
PYHIN1	"IFIX, MGC23885"	ENSG00000163564	"Pyrin and HIN domain family member 1"	Q6K0P9	1	158930796-158977059	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 23.1"	"Group enriched"	"Detected in some"	12	"NK-cells: 289.6;T-cells: 96.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 97.3;MAIT T-cell: 56.3;memory CD4 T-cell: 40.8;memory CD8 T-cell: 74.7;naive CD8 T-cell: 45.1;NK-cell: 36.8;T-reg: 67.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 36.8;T-cells: 97.3"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 13.8"	"Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Prostate - T-cells, Thyroid - T-cells"									"HPA051224, HPA055373"	Enhanced		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoli	Nucleoplasm	"HPA051224: AB_2681394, HPA055373: "	"unprognostic (1.64e-3)"	"unprognostic (1.75e-3)"	"unprognostic (2.93e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.99e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.44e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-6)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.45e-3)"
SH2D2A	"F2771, TSAd"	ENSG00000027869	"SH2 domain containing 2A"	Q9NP31	1	156806243-156816848	"Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 14.9"	"Group enriched"	"Detected in many"	4	"NK-cells: 203.0;T-cells: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	30	"NK-cells: 28.5;T-cells: 66.5"	"Group enriched"	"Detected in many"	6	"Leukemia: 12.8;lymphoma: 31.9;Myeloma: 12.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Fibroblasts, Lung - NK-cells (Lung), Skin - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 1.6"	HPA074482	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA074482: "	"prognostic favorable (4.96e-4)"	"unprognostic (2.76e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.14e-3)"	"unprognostic (2.73e-1)"	"unprognostic (3.11e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (5.26e-12)"	"unprognostic (1.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (1.31e-4)"
SHISAL2A	"FAM159A, MGC52498"	ENSG00000182183	"Shisa like 2A"	Q6UWV7	1	52633168-52669683	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.7;intestine: 3.7;lymphoid tissue: 5.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;NK-cells: 20.2;Plasma cells: 9.2;T-cells: 20.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"hypothalamus: 8.7"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 10.1;NK-cells: 5.9;T-cells: 7.0"	"Group enriched"	"Detected in some"	9	"Leukemia: 1.3;lymphoma: 3.3;Myeloma: 4.2"	"Adipose visceral - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.0"	"Low region specificity"	"Detected in some"			HPA030744	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 62: B-cells - B-cell activation"			"HPA030744: AB_10963060"	"unprognostic (7.94e-6)"	"unprognostic (8.50e-3)"	"unprognostic (8.29e-3)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.67e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.64e-2)"
SIT1	SIT	ENSG00000137078	"Signaling threshold regulating transmembrane adaptor 1"	Q9Y3P8	9	35649295-35650950	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 95.4"	"Group enriched"	"Detected in some"	7	"B-cells: 80.9;dendritic cells: 39.5;Plasma cells: 23.8;T-cells: 80.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	46	"gdT-cell: 119.1;MAIT T-cell: 202.7;memory B-cell: 213.6;memory CD4 T-cell: 249.2;memory CD8 T-cell: 223.4;naive B-cell: 192.1;naive CD4 T-cell: 170.4;naive CD8 T-cell: 169.5;plasmacytoid DC: 203.1;T-reg: 352.4"	"Group enriched"	"Detected in many"	56	"B-cells: 213.6;dendritic cells: 203.1;T-cells: 352.4"	"Group enriched"	"Detected in some"	9	"Leukemia: 22.7;lymphoma: 66.8"	"Colon - T-cells, Lung - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA018506	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"			"HPA018506: AB_2669896"	"unprognostic (4.28e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (8.01e-3)"	"prognostic favorable (1.94e-6)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-4)"	"unprognostic (1.75e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (8.17e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.34e-2)"
SKAP1	"SCAP1, SKAP55"	ENSG00000141293	"Src kinase associated phosphoprotein 1"	Q86WV1	17	48133442-48430275	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 115.5;Late spermatids: 158.4;NK-cells: 174.0;T-cells: 146.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"Myeloma: 20.2;Rhabdoid: 27.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - Hepatocytes, Lung - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002969, CAB025882, CAB055513"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 7: NK-cells - Immune response regulation"	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB025882: , CAB055513: , HPA002969: AB_1079870"	"prognostic favorable (5.07e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.14e-4)"
SLAMF1	"CD150, SLAM"	ENSG00000117090	"Signaling lymphocytic activation molecule family member 1"	Q13291	1	160608106-160647295	"CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Cell adhesion, Host-virus interaction, Immunity, Innate immunity, Phagocytosis"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 76.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 25.6;Langerhans cells: 10.1;Plasma cells: 41.1;T-cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 66.3"	"Group enriched"	"Detected in many"	10	"B-cells: 22.7;T-cells: 66.3"	"Cancer enhanced"	"Detected in some"		"Leukemia: 13.5;lymphoma: 38.5"	"Adipose subcutaneous - T-cells, Liver - T-cells, Prostate - T-cells, Skin - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002438, HPA069319"	Enhanced				"Secreted to blood"	NA	NA		350000	"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 9: Lymphoid cancers - Immune response"	"Cluster 1: T-cells - Immune response"			"CAB002438: AB_564011, HPA069319: AB_2732129"	"unprognostic (2.99e-3)"	"unprognostic (3.33e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.38e-4)"	"unprognostic (5.87e-2)"	"unprognostic (6.06e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.74e-4)"	"unprognostic (6.12e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-7)"	"unprognostic (2.46e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-2)"
SLAMF6	"CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000"	ENSG00000162739	"SLAM family member 6"	Q96DU3	1	160485030-160523262	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 61.7"	"Group enriched"	"Detected in some"	5	"B-cells: 22.0;Late spermatids: 23.2;NK-cells: 39.8;Plasma cells: 18.2;Serous glandular cells: 12.7;T-cells: 34.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Leukemia: 9.2;lymphoma: 34.1"	"Breast - Plasma cells, Colon - T-cells, Liver - T-cells, Lung - T-cells, Prostate - T-cells, Stomach - T-cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051363, HPA051903"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	"Plasma membrane, Cytosol"		"HPA051363: AB_2681454, HPA051903: AB_2681658"	"prognostic favorable (9.42e-4)"	"prognostic favorable (2.78e-4)"	"unprognostic (8.65e-2)"	"prognostic favorable (9.53e-4)"	"unprognostic (5.85e-2)"	"prognostic favorable (7.34e-5)"	"unprognostic (3.16e-3)"	"unprognostic (9.78e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.21e-3)"
SLAMF7	"19A, CD319, CRACC, CS1"	ENSG00000026751	"SLAM family member 7"	Q9NQ25	1	160739057-160754821	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6;lymphoid tissue: 62.0;stomach 1: 34.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 80.9;monocytes: 44.3;NK-cells: 64.1;Plasma cells: 243.3;Schwann cells: 66.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	7	"Myeloma: 184.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Heart muscle - T-cells, Liver - T-cells, Lung - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015445, HPA055945, HPA061654"	Enhanced		Approved	Vesicles		NA	NA		1200000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 40: Plasma cells - Humoral immune response"	Vesicles		"CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.46e-2)"	"prognostic favorable (3.93e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.57e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-2)"
STAT4		ENSG00000138378	"Signal transducer and activator of transcription 4"	Q14765	2	191029576-191151596	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;testis: 29.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 65.7;Early spermatids: 320.6;Excitatory neurons: 84.7;Late spermatids: 77.7;NK-cells: 226.8;T-cells: 125.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 76.6;T-cells: 121.2"	"Cancer enhanced"	"Detected in many"		"Myeloma: 7.4"	"Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells, Prostate - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001860, CAB013108"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 1: T-cells - Immune response"			"CAB013108: , HPA001860: AB_1080104"	"unprognostic (3.90e-5)"	"unprognostic (1.30e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.49e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.07e-8)"	"unprognostic (2.65e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"
TRAF3IP3	T3JAM	ENSG00000009790	"TRAF3 interacting protein 3"	Q9Y228	1	209756032-209782320	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 130.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 125.8;granulocytes: 60.4;monocytes: 103.7;NK-cells: 236.2;T-cells: 162.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"Leukemia: 46.3;lymphoma: 40.5;Myeloma: 68.6"	"Adipose subcutaneous - T-cells, Heart muscle - T-cells, Liver - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040796	Enhanced		Approved	Vesicles		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 7: NK-cells - Immune response regulation"	Vesicles		"HPA040796: AB_10794861"	"prognostic favorable (4.11e-4)"	"unprognostic (1.11e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.36e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.91e-5)"	"unprognostic (3.83e-3)"	"prognostic favorable (8.15e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-4)"	"unprognostic (3.08e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.21e-2)"
TRAV12-1		ENSG00000211785	"T cell receptor alpha variable 12-1"	A0A0B4J245	14	21841240-21841774	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 1.9;Gastric mucus-secreting cells: 2.4;Plasma cells: 1.1;T-cells: 6.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	72	"MAIT T-cell: 128.5;memory CD4 T-cell: 205.2;memory CD8 T-cell: 199.7;naive CD4 T-cell: 138.6;naive CD8 T-cell: 251.7;T-reg: 193.9"	"Lineage enriched"	"Detected in many"	97	"T-cells: 251.7"	"Cancer enriched"	"Detected in single"	217	"Leukemia: 21.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (4.83e-3)"	"unprognostic (9.56e-5)"	"unprognostic (2.18e-2)"	"unprognostic (3.33e-3)"		"unprognostic (8.05e-2)"	"unprognostic (2.99e-4)"	"unprognostic (3.16e-4)"	"unprognostic (3.23e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.97e-4)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.92e-2)"
TRAV12-2		ENSG00000211789	"T cell receptor alpha variable 12-2"	A0A075B6T6	14	21887857-21888502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 22.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 9.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	17	"memory CD4 T-cell: 101.9;memory CD8 T-cell: 87.7;naive CD4 T-cell: 90.3;naive CD8 T-cell: 65.2;T-reg: 143.3"	"Lineage enriched"	"Detected in many"	77	"T-cells: 143.3"	"Cancer enriched"	"Detected in single"	328	"lymphoma: 32.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.73e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.74e-2)"	"unprognostic (4.98e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.22e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.23e-4)"	"unprognostic (1.73e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.01e-2)"
TRAV12-3	"TCRAV12S3, TCRAV2S2, TRAV123"	ENSG00000211794	"T cell receptor alpha variable 12-3"	A0A0B4J271	14	21965451-21966061	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 60.3"	"Cell type enriched"	"Detected in some"	4	"T-cells: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD4 T-cell: 186.5;T-reg: 256.6"	"Lineage enriched"	"Detected in many"	23	"T-cells: 256.6"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.62e-4)"	"unprognostic (7.68e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.55e-4)"	"unprognostic (9.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.52e-5)"	"unprognostic (3.75e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.68e-2)"
TRAV13-1		ENSG00000211788	"T cell receptor alpha variable 13-1"	A0A0B4J241	14	21868839-21869365	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lymphoid tissue: 62.5"	"Cell type enriched"	"Detected in single"	29	"T-cells: 14.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 329.3"	"Lineage enriched"	"Detected in many"	28	"T-cells: 329.3"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.10e-3)"	"unprognostic (9.80e-3)"	"unprognostic (1.60e-2)"	"unprognostic (3.04e-3)"	"unprognostic (5.71e-2)"	"unprognostic (3.30e-5)"	"unprognostic (7.68e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.59e-2)"
TRAV13-2		ENSG00000211791	"T cell receptor alpha variable 13-2"	A0A0B4J235	14	21918188-21918756	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in some"		"NK-cells: 2.0;Prostatic glandular cells: 1.8;T-cells: 6.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	38	"MAIT T-cell: 32.9;memory CD4 T-cell: 94.0;memory CD8 T-cell: 57.3;naive CD4 T-cell: 101.8;naive CD8 T-cell: 114.1;T-reg: 114.8"	"Lineage enriched"	"Detected in many"	53	"T-cells: 114.8"	"Group enriched"	"Detected in some"	4	"lymphoma: 2.8;Rhabdoid: 1.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.15e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.26e-3)"	"unprognostic (5.58e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.66e-4)"	"unprognostic (1.52e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.77e-2)"
TRAV14DV4	"hADV14S1, TCRAV6S1-hDV104S1, TRAV14/DV4"	ENSG00000211792	"T cell receptor alpha variable 14/delta variable 4"	A0A0A6YYC5	14	21924063-21924651	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 25.7"	"Cell type enriched"	"Detected in single"	10	"T-cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"memory CD4 T-cell: 38.2;memory CD8 T-cell: 78.1;naive CD4 T-cell: 30.7;naive CD8 T-cell: 122.3;T-reg: 42.6"	"Lineage enriched"	"Detected in single"	176	"T-cells: 122.3"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.82e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.06e-3)"		"unprognostic (3.00e-5)"	"unprognostic (2.52e-1)"	"unprognostic (7.61e-4)"	"unprognostic (3.77e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.62e-5)"	"unprognostic (3.01e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.60e-2)"
TRAV17	"TCRAV17S1, TCRAV3S1"	ENSG00000211797	"T cell receptor alpha variable 17"	A0A0B4J275	14	21997539-21998168	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 27.8"	"Cell type enriched"	"Detected in single"	8	"T-cells: 7.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	19	"memory CD4 T-cell: 81.4;memory CD8 T-cell: 63.7;naive CD4 T-cell: 61.8;naive CD8 T-cell: 53.2;T-reg: 116.3"	"Lineage enriched"	"Detected in single"	226	"T-cells: 116.3"	"Cancer enhanced"	"Detected in single"		"Rhabdoid: 1.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (8.22e-4)"	"unprognostic (4.50e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.06e-2)"		"unprognostic (2.72e-6)"	"unprognostic (6.44e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (8.43e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.21e-1)"
TRAV2		ENSG00000211776	"T cell receptor alpha variable 2"	A0A0B4J234	14	21712321-21712843	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	21	"lymphoid tissue: 56.3"	"Cell type enriched"	"Detected in single"	29	"T-cells: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 40.9"	"Lineage enriched"	"Detected in single"	124	"T-cells: 40.9"	"Cancer enhanced"	"Detected in some"		"Leukemia: 12.8;lymphoma: 3.2"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.38e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.93e-2)"		"unprognostic (1.86e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.93e-5)"	"unprognostic (1.92e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.45e-2)"
TRAV21		ENSG00000211801	"T cell receptor alpha variable 21"	A0A0B4J279	14	22052514-22053056	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"lymphoid tissue: 63.2"	"Cell type enriched"	"Detected in some"	6	"T-cells: 24.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 220.5;memory CD8 T-cell: 233.5;naive CD4 T-cell: 198.6;naive CD8 T-cell: 204.8;T-reg: 391.9"	"Lineage enriched"	"Detected in many"	76	"T-cells: 391.9"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"					"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"		"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.53e-4)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-3)"	"unprognostic (3.69e-4)"	"unprognostic (1.74e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.20e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"
TRAV4	"TCRAV20S1, TCRAV4S1"	ENSG00000211778	"T cell receptor alpha variable 4"	A0A0B4J268	14	21736152-21736982	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 37.9"	"Cell type enriched"	"Detected in single"	9	"T-cells: 7.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	70	"MAIT T-cell: 66.1;memory CD4 T-cell: 81.9;memory CD8 T-cell: 124.0;naive CD4 T-cell: 77.1;naive CD8 T-cell: 81.0;T-reg: 167.9"	"Lineage enriched"	"Detected in many"	118	"T-cells: 167.9"	"Group enriched"	"Detected in some"	54	"Bone cancer: 2.5;Leukemia: 8.1"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.13e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.18e-4)"	"unprognostic (1.34e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-3)"	"unprognostic (8.68e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.37e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (6.49e-2)"
TRAV8-2		ENSG00000211786	"T cell receptor alpha variable 8-2"	A0A0B4J237	14	21846537-21847221	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 24.1"	"Cell type enriched"	"Detected in single"	15	"T-cells: 12.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	99	"MAIT T-cell: 59.1;memory CD4 T-cell: 143.4;memory CD8 T-cell: 81.1;naive CD4 T-cell: 143.2;naive CD8 T-cell: 80.1;T-reg: 190.6"	"Lineage enriched"	"Detected in many"	184	"T-cells: 190.6"	"Group enriched"	"Detected in some"	7	"Leukemia: 1.1;lymphoma: 2.8;Rhabdoid: 1.5"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - Podocytes, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (5.88e-3)"	"unprognostic (9.98e-4)"	"unprognostic (2.31e-2)"	"unprognostic (2.23e-2)"		"unprognostic (9.88e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.22e-3)"	"unprognostic (9.30e-3)"	"unprognostic (2.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.57e-5)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.02e-1)"
TRAV8-3		ENSG00000211787	"T cell receptor alpha variable 8-3"	A0A0A6YYJ7	14	21852558-21853006	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 71.1"	"Cell type enriched"	"Detected in single"	17	"T-cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.2"	"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 138.2;T-reg: 153.1"	"Lineage enriched"	"Detected in many"	47	"T-cells: 153.1"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"					"Low region specificity"	"Detected in single"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (7.74e-4)"	"unprognostic (5.25e-5)"	"unprognostic (8.88e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (9.64e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"
TRAV8-6		ENSG00000211795	"T cell receptor alpha variable 8-6"	A0A0B4J262	14	21978459-21979120	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	12	"lymphoid tissue: 24.7"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 1.8;T-cells: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 89.3;memory CD8 T-cell: 64.2;naive CD4 T-cell: 92.6;naive CD8 T-cell: 38.7;T-reg: 125.0"	"Lineage enriched"	"Detected in many"	45	"T-cells: 125.0"	"Group enriched"	"Detected in some"	17	"lymphoma: 3.6;Rhabdoid: 14.0"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: Rhabdoid cancers - Neuronal signaling"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.42e-2)"	"unprognostic (9.23e-4)"	"unprognostic (5.47e-3)"	"unprognostic (1.27e-3)"	"unprognostic (7.80e-2)"	"unprognostic (7.74e-5)"	"unprognostic (2.88e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.24e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.92e-1)"	"unprognostic (9.78e-5)"	"unprognostic (4.65e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.61e-3)"
TRAV9-2		ENSG00000211793	"T cell receptor alpha variable 9-2"	A0A087WT02	14	21941128-21941657	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"lymphoid tissue: 27.8"	"Cell type enriched"	"Detected in single"	8	"T-cells: 6.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 178.3;naive CD4 T-cell: 172.2;T-reg: 350.8"	"Lineage enriched"	"Detected in many"	78	"T-cells: 350.8"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"		"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.02e-3)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.25e-4)"		"unprognostic (1.14e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.98e-4)"	"unprognostic (9.53e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.00e-4)"	"unprognostic (2.49e-1)"	"unprognostic (4.28e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.56e-2)"
TRBJ2-1	"TCRBJ2S1, TRBJ21"	ENSG00000211764	"T cell receptor beta joining 2-1"	A0A0A0MTA7	7	142796365-142796414	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	6	"bone marrow: 26.8;lymphoid tissue: 71.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 8.7"	"Immune cell enhanced"	"Detected in all"		"T-reg: 1684.5"	"Lineage enriched"	"Detected in all"	8	"T-cells: 1684.5"	"Cancer enhanced"	"Detected in many"		"Leukemia: 82.1"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.57e-2)"	"prognostic favorable (8.15e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"		"unprognostic (2.30e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.12e-2)"		"unprognostic (3.74e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.07e-2)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (2.31e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.65e-3)"
TRBJ2-3	"TCRBJ2S3, TRBJ23"	ENSG00000211767	"T cell receptor beta joining 2-3"	A0A0B4J200	7	142796847-142796895	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"thalamus: 19.7"	"Group enriched"	"Detected in all"	12	"gdT-cell: 1486.3;MAIT T-cell: 905.3;memory B-cell: 1210.1;memory CD4 T-cell: 1124.0;memory CD8 T-cell: 1154.0;naive B-cell: 1430.2;naive CD4 T-cell: 1106.3;naive CD8 T-cell: 1031.1;NK-cell: 933.5;T-reg: 2317.4"	"Group enriched"	"Detected in all"	15	"B-cells: 1430.2;NK-cells: 933.5;T-cells: 2317.4"	"Group enriched"	"Detected in many"	6	"Leukemia: 75.4;lymphoma: 156.8;Myeloma: 50.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 23: B-cell cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (4.65e-3)"	"unprognostic (7.01e-3)"	"unprognostic (7.69e-2)"	"prognostic favorable (1.47e-5)"		"unprognostic (1.76e-5)"	"unprognostic (1.18e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.84e-3)"	"unprognostic (1.25e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-3)"
TRBJ2-7	"TCRBJ2S7, TRBJ27"	ENSG00000211771	"T cell receptor beta joining 2-7"	A0A0A0MT78	7	142797456-142797502	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.4;lymphoid tissue: 155.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"thalamus: 10.8"	"Group enriched"	"Detected in all"	7	"MAIT T-cell: 1275.2;memory CD4 T-cell: 2387.1;memory CD8 T-cell: 2649.6;naive CD4 T-cell: 2393.9;naive CD8 T-cell: 2831.0;T-reg: 4224.6"	"Lineage enriched"	"Detected in all"	18	"T-cells: 4224.6"	"Cancer enhanced"	"Detected in many"		"Leukemia: 87.6;lymphoma: 31.5"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (9.07e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.37e-2)"	"prognostic favorable (4.79e-4)"		"unprognostic (1.14e-3)"	"unprognostic (2.57e-3)"	"unprognostic (6.68e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.17e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (7.27e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.13e-3)"
TRBV10-3	"TCRBV10S3, TCRBV12S1A1N2, TRBV103"	ENSG00000275791	"T cell receptor beta variable 10-3"	A0A0K0K1G6	7	142544212-142544685	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	31	"lymphoid tissue: 88.6"	"Group enriched"	"Detected in some"	4	"Basal squamous epithelial cells: 1.8;Late spermatids: 1.7;T-cells: 5.1"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 160.1;T-reg: 203.1"	"Lineage enriched"	"Detected in single"	375	"T-cells: 203.1"	"Cancer enriched"	"Detected in single"	27	"Leukemia: 3.5"	"Adipose visceral - T-cells, Breast - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.61e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.44e-2)"	"unprognostic (8.96e-3)"	"unprognostic (3.16e-1)"	"unprognostic (4.23e-6)"	"unprognostic (9.84e-4)"	"unprognostic (7.96e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.99e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.59e-6)"	"unprognostic (5.93e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-3)"
TRBV19	"TCRBV17S1A1T, TCRBV19S1"	ENSG00000211746	"T cell receptor beta variable 19"	A0A075B6N1	7	142618849-142619532	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"lymphoid tissue: 53.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 50.8;memory CD8 T-cell: 40.2;naive CD4 T-cell: 71.1;naive CD8 T-cell: 53.5;T-reg: 88.5"	"Lineage enriched"	"Detected in single"	191	"T-cells: 88.5"	"Cancer enriched"	"Detected in single"	14	"Leukemia: 1.4"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.62e-3)"	"unprognostic (8.91e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.38e-2)"	"unprognostic (2.29e-4)"	"unprognostic (3.96e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"
TRBV2	"TCRBV22S1A2N1T, TCRBV2S1"	ENSG00000226660	"T cell receptor beta variable 2"	A0A1B0GX68	7	142300924-142301432	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"lymphoid tissue: 89.2"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 14.0;T-cells: 7.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 120.3;memory CD8 T-cell: 64.5;naive CD4 T-cell: 71.5;naive CD8 T-cell: 44.5;T-reg: 122.7"	"Lineage enriched"	"Detected in many"	21	"T-cells: 122.7"	"Cancer enriched"	"Detected in single"	18	"lymphoma: 2.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.62e-4)"	"unprognostic (4.94e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-5)"	"unprognostic (3.60e-2)"	"unprognostic (3.74e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.70e-5)"	"unprognostic (3.83e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.41e-2)"
TRBV24-1	"TCRBV15S1, TCRBV24S1, TRBV241"	ENSG00000211750	"T cell receptor beta variable 24-1"	A0A075B6N3	7	142656701-142657213	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 2.7;lymphoid tissue: 6.7"	"Cell type enriched"	"Detected in single"	4	"T-cells: 4.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.7"	"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 26.6"	"Lineage enriched"	"Detected in single"	129	"T-cells: 26.6"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Prostate - T-cells, Skeletal muscle - Skeletal myocytes, Thyroid - T-cells"															NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.42e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-7)"	"unprognostic (2.36e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.39e-2)"
TRBV29-1	"TCRBV29S1, TCRBV4S1A1T, TRBV291"	ENSG00000232869	"T cell receptor beta variable 29-1"	A0A5B7	7	142740206-142740894	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 98.5"	"Cell type enriched"	"Detected in single"	15	"T-cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	44	"MAIT T-cell: 45.1;memory CD4 T-cell: 128.6;memory CD8 T-cell: 83.2;naive CD4 T-cell: 137.8;naive CD8 T-cell: 110.8;T-reg: 178.2"	"Lineage enriched"	"Detected in many"	69	"T-cells: 178.2"	"Cancer enriched"	"Detected in single"	11	"Myeloma: 1.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"													NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 2: T-cells - T-cell receptor"				"prognostic favorable (1.23e-4)"	"unprognostic (9.31e-4)"	"unprognostic (1.29e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.47e-4)"	"unprognostic (6.84e-3)"	"unprognostic (1.71e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.05e-1)"
TRBV3-1	"TCRBV3S1, TCRBV9S1A1T, TRBV31"	ENSG00000237702	"T cell receptor beta variable 3-1"	A0A576	7	142308542-142309048	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	22	"lymphoid tissue: 51.1"	"Group enriched"	"Detected in some"	15	"Plasma cells: 7.0;T-cells: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 52.4;memory CD8 T-cell: 45.9;naive CD4 T-cell: 71.6;naive CD8 T-cell: 117.4;T-reg: 99.6"	"Lineage enriched"	"Detected in many"	32	"T-cells: 117.4"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (7.98e-5)"	"unprognostic (2.38e-3)"	"unprognostic (5.19e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.19e-4)"	"unprognostic (1.46e-2)"	"unprognostic (5.42e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.01e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.26e-2)"
TRBV4-1	"BV07S1J2.7, TCRBV4S1, TCRBV7S1A1N2T, TRBV41"	ENSG00000211710	"T cell receptor beta variable 4-1"	A0A577	7	142313184-142313666	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	27	"lymphoid tissue: 115.0"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 4.2;T-cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 176.7"	"Lineage enriched"	"Detected in many"	89	"T-cells: 176.7"	"Cancer enriched"	"Detected in single"	71	"lymphoma: 11.0"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.58e-4)"	"unprognostic (3.14e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (6.71e-5)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.99e-2)"
TRBV4-2	"TCRBV4S2, TCRBV7S3A2T, TRBV42"	ENSG00000211745	"T cell receptor beta variable 4-2"	A0A539	7	142345421-142345985	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 21.0"	"Cell type enriched"	"Detected in some"	7	"T-cells: 24.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 100.2"	"Lineage enriched"	"Detected in single"	293	"T-cells: 100.2"	"Cancer enriched"	"Detected in single"	250	"Leukemia: 29.6"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (2.89e-3)"	"unprognostic (4.65e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.06e-2)"	"unprognostic (4.60e-2)"	"unprognostic (7.05e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.32e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.82e-4)"	"unprognostic (5.50e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.48e-2)"
TRBV5-4	"TCRBV5S4, TCRBV5S6A3N2T, TRBV54"	ENSG00000230099	"T cell receptor beta variable 5-4"	A0A0C4DH59	7	142462916-142463581	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 22.1;pancreas: 11.6"	"Group enriched"	"Detected in some"	8	"Plasma cells: 4.1;T-cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 115.7"	"Lineage enriched"	"Detected in many"	115	"T-cells: 115.7"	"Group enriched"	"Detected in some"	6	"Leukemia: 3.3;ovarian cancer: 1.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.48e-3)"	"unprognostic (6.75e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.60e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.64e-2)"
TRBV5-6	"TCRBV5S2, TCRBV5S6, TRBV56"	ENSG00000211728	"T cell receptor beta variable 5-6"	A0A599	7	142500028-142500534	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	19	"lymphoid tissue: 33.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.7;Late spermatids: 16.3;T-cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	14	"memory CD4 T-cell: 40.2;memory CD8 T-cell: 22.9;naive CD4 T-cell: 35.9;naive CD8 T-cell: 45.2;T-reg: 66.0"	"Lineage enriched"	"Detected in many"	56	"T-cells: 66.0"	"Cancer enriched"	"Detected in single"	416	"Leukemia: 44.6"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.27e-3)"	"unprognostic (8.46e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.45e-4)"	"unprognostic (5.72e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.26e-7)"	"unprognostic (7.62e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.34e-1)"
TRBV6-2	"TCRBV13S2A1T, TCRBV6S2, TRBV62"	ENSG00000283063	"T cell receptor beta variable 6-2"	"A0A0J9YXY3, P0DPF7"	7	142349152-142349664	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 8.2"	"Group enriched"	"Detected in some"	7	"Erythroid cells: 1.9;T-cells: 7.5"					"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 92.1"	"Lineage enriched"	"Detected in single"	175	"T-cells: 92.1"	"Not detected"	"Not detected"			"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"																				
TRBV6-5	"TCRBV13S1, TCRBV6S5, TRBV65"	ENSG00000211721	"T cell receptor beta variable 6-5"	A0A0K0K1A5	7	142450947-142451448	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"lymphoid tissue: 82.3"	"Cell type enriched"	"Detected in single"	58	"T-cells: 11.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive CD8 T-cell: 133.8;T-reg: 137.9"	"Lineage enriched"	"Detected in many"	54	"T-cells: 137.9"	"Cancer enriched"	"Detected in single"	70	"Leukemia: 23.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Prostate - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (6.42e-3)"	"unprognostic (7.43e-4)"	"unprognostic (1.11e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.63e-5)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.11e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.82e-1)"	"prognostic unfavorable (5.40e-5)"	"unprognostic (3.12e-2)"	"unprognostic (4.17e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.06e-2)"
TRBV6-6	"TCRBV13S6A2T, TCRBV6S6, TRBV66"	ENSG00000211724	"T cell receptor beta variable 6-6"	A0A0A6YYG2	7	142469537-142470013	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 14.7"	"Cell type enriched"	"Detected in single"	35	"T-cells: 3.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 81.4"	"Lineage enriched"	"Detected in single"	98	"T-cells: 81.4"	"Cancer enriched"	"Detected in single"	39	"Leukemia: 8.8"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.69e-4)"	"unprognostic (3.82e-4)"	"unprognostic (3.66e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.93e-5)"	"unprognostic (4.36e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.01e-2)"
TRBV7-9	"TCRBV6S4A1, TCRBV7S9, TRBV79"	ENSG00000278030	"T cell receptor beta variable 7-9"	P04435	7	142529290-142529762	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"lymphoid tissue: 55.4"	"Cell type enriched"	"Detected in some"	4	"T-cells: 21.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	37	"memory CD4 T-cell: 48.4;memory CD8 T-cell: 81.7;naive CD4 T-cell: 67.3;naive CD8 T-cell: 73.5;T-reg: 95.1"	"Lineage enriched"	"Detected in many"	87	"T-cells: 95.1"	"Cancer enriched"	"Detected in single"	91	"Leukemia: 17.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (3.18e-3)"	"unprognostic (5.05e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.48e-5)"	"unprognostic (1.04e-1)"	"prognostic favorable (4.68e-5)"	"unprognostic (1.12e-3)"	"unprognostic (1.05e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.40e-2)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (1.34e-5)"	"unprognostic (3.17e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"
TRBV9	"TCRBV1S1A1N1, TCRBV9S1"	ENSG00000211716	"T cell receptor beta variable 9"	A0A0B4J1U6	7	142391891-142392412	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.1;testis: 2.6"	"Group enriched"	"Detected in some"	10	"Early spermatids: 5.4;Late spermatids: 5.0;T-cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"memory CD4 T-cell: 20.0;memory CD8 T-cell: 21.7;naive CD4 T-cell: 14.8;naive CD8 T-cell: 13.2;T-reg: 27.2"	"Lineage enriched"	"Detected in single"	31	"T-cells: 27.2"	"Cancer enhanced"	"Detected in single"		"Sarcoma: 1.1"	"Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"															NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (7.28e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.58e-4)"	"unprognostic (8.88e-3)"	"unprognostic (6.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.60e-10)"	"unprognostic (1.04e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.46e-3)"
TRGC1	"C1, TCRGC1"	ENSG00000211689	"T cell receptor gamma constant 1"		7	38257879-38265678	"Predicted membrane proteins, T-cell receptor genes"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"bone marrow: 31.7;prostate: 76.6"	"Group enriched"	"Detected in some"	14	"NK-cells: 195.1;Prostatic glandular cells: 166.2;T-cells: 67.7"	"Cancer enriched"	"Detected in some"	141	"prostate cancer: 107.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"gdT-cell: 384.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 384.7"	"Cancer enriched"	"Detected in some"	6	"prostate cancer: 52.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Prostate - Prostate glandular cells, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 24: Prostate cancer - Lipid metabolism"	"Cluster 7: NK-cells - Immune response regulation"				"unprognostic (2.37e-2)"	"unprognostic (2.38e-4)"	"unprognostic (3.43e-3)"	"unprognostic (6.04e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.33e-3)"	"unprognostic (3.80e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.56e-2)"
TRGV10	"TCRGV10, V3P"	ENSG00000211694	"T cell receptor gamma variable 10 (non-functional)"		7	38299811-38300322	"Predicted intracellular proteins, T-cell receptor genes"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1;lymphoid tissue: 13.9"	"Cell type enriched"	"Detected in some"	4	"T-cells: 27.0"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 7.3"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 196.5"	"Lineage enriched"	"Detected in many"	8	"T-cells: 196.5"	"Group enriched"	"Detected in some"	6	"Leukemia: 5.2;prostate cancer: 1.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Lung - NK-cells (Lung), Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.59e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.22e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-4)"	"unprognostic (2.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.07e-2)"
TRGV2	"TCRGV2, VIS2"	ENSG00000233306	"T cell receptor gamma variable 2"	A0A075B6R0	7	38362864-38363518	"Predicted intracellular proteins, T-cell receptor genes"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 6.6"	"Cell type enriched"	"Detected in some"	6	"T-cells: 18.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory CD8 T-cell: 147.8"	"Lineage enriched"	"Detected in many"	22	"T-cells: 147.8"	"Group enriched"	"Detected in some"	13	"Leukemia: 3.9;lymphoma: 1.8;Myeloma: 3.2"	"Adipose visceral - T-cells, Breast - T-cells, Colon - T-cells, Thyroid - T-cells"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 2: T-cells - T-cell receptor"				"unprognostic (1.51e-3)"	"unprognostic (8.88e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.31e-4)"	"unprognostic (1.50e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.21e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-3)"
TSPAN32	"PHEMX, TSSC6"	ENSG00000064201	"Tetraspanin 32"	Q96QS1	11	2301997-2318204	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.9;Erythroid cells: 22.0;granulocytes: 15.6;Langerhans cells: 24.8;monocytes: 37.1;NK-cells: 68.3;T-cells: 20.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	5	"Leukemia: 8.8"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Heart muscle - Cardiomyocytes, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA024135	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 66: Myeloid cells - Innate immune response"	"Cluster 7: NK-cells - Immune response regulation"	Nucleoplasm		"HPA024135: AB_1858409"	"unprognostic (7.50e-3)"	"unprognostic (4.88e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.45e-3)"	"unprognostic (2.10e-4)"	"unprognostic (7.72e-3)"	"unprognostic (8.25e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-7)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.13e-2)"
TTC16	FLJ32780	ENSG00000167094	"Tetratricopeptide repeat domain 16"	Q8NEE8	9	127716079-127731590	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"fallopian tube: 6.9;testis: 16.0"	"Group enriched"	"Detected in some"	6	"Early spermatids: 91.0;Late spermatids: 259.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 1.6;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Liver - T-cells, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 6: Late spermatids - Spermatogenesis"				"unprognostic (3.10e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.86e-3)"	"unprognostic (2.02e-4)"	"unprognostic (4.08e-3)"	"unprognostic (2.25e-3)"	"unprognostic (8.87e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.35e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.54e-3)"
XCL1	"ATAC, LPTN, LTN, SCM-1, SCM-1a, SCYC1"	ENSG00000143184	"X-C motif chemokine ligand 1"	P47992	1	168576605-168582069	"Predicted secreted proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.6"	"Group enriched"	"Detected in many"	13	"NK-cells: 202.0;T-cells: 209.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"NK-cell: 88.5"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 88.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.1"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Liver - NK-cells (Liver), Prostate - T-cells, Thyroid - T-cells"	"Not detected"	"Not detected"							HPA057725	Approved				"Secreted to blood"	NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 1: T-cells - Immune response"			"HPA057725: AB_2683511"	"unprognostic (5.38e-3)"	"unprognostic (5.72e-2)"	"unprognostic (8.23e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.34e-10)"	"unprognostic (1.96e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.15e-2)"
ZBP1	"C20orf183, DAI, dJ718J7.3, DLM-1, DLM1"	ENSG00000124256	"Z-DNA binding protein 1"	Q9H171	20	57603846-57620576	"Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Necrosis"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.7;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	5	"NK-cells: 68.4;Plasma cells: 159.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"Myeloma: 50.6"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Colon - T-cells, Heart muscle - T-cells, Thyroid - T-cells"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA041256	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: Myeloma - Humoral immune response"	"Cluster 40: Plasma cells - Humoral immune response"			"HPA041256: AB_2677380"	"unprognostic (5.78e-3)"	"unprognostic (9.86e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.05e-4)"	"unprognostic (1.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.58e-8)"	"unprognostic (8.29e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-2)"	"unprognostic (9.79e-2)"
ZNF683	"Hobit, MGC33414"	ENSG00000176083	"Zinc finger protein 683"	Q8IZ20	1	26361634-26374522	"Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 81.9"	"Group enriched"	"Detected in some"	14	"Early spermatids: 346.9;Late spermatids: 550.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 172.4;memory CD8 T-cell: 113.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 172.4"	"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.2"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Lung - T-cells, Pancreas - T-cells, Testis - Late spermatids, Thyroid - T-cells"					"Not detected"	"Not detected"			HPA023865	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: Lymphoid cancers - Adaptive immune response"	"Cluster 24: Spermatids - Unknown function"			"HPA023865: AB_2671333"	"unprognostic (3.95e-3)"	"unprognostic (5.58e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (2.90e-5)"	"unprognostic (9.17e-2)"	"unprognostic (8.98e-4)"	"unprognostic (7.90e-2)"	"unprognostic (5.05e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.54e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (3.45e-5)"
ZNF80	pT17	ENSG00000174255	"Zinc finger protein 80"	P51504	3	114234631-114237578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"lymphoid tissue: 3.1"	"Group enriched"	"Detected in some"	5	"NK-cells: 3.6;Pancreatic endocrine cells: 3.4;T-cells: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.2"	"Cancer enriched"	"Detected in single"	6	"lymphoma: 1.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Breast - T-cells, Kidney - T-cells"									HPA065484	Uncertain					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 7: NK-cells - Immune response regulation"			"HPA065484: AB_2685496"	"unprognostic (6.27e-3)"	"unprognostic (3.00e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.68e-5)"	"unprognostic (5.36e-1)"	"unprognostic (6.52e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.69e-12)"	"unprognostic (1.85e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.34e-2)"